New hope for tough sarcomas: trial tests safer, targeted drug combo
NCT ID NCT07359053
Summary
This study is testing a new three-drug combination for people with advanced bone or soft tissue sarcomas that have worsened after initial treatment. It aims to see if this combination can better control tumor growth while possibly causing fewer side effects than current options. The trial will enroll about 46 patients and closely monitor how their tumors respond and how they feel during treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Sixth Peolple'S Hospital
RECRUITINGShanghai, CH, 200233, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.